Dibucain
Brand names,
Dibucain
Analogs
Dibucain
Brand Names Mixture
Dibucain
Chemical_Formula
C21H27NO
Dibucain
RX_link
No information avaliable
Dibucain
fda sheet
Dibucain
msds (material safety sheet)
Dibucain
Synthesis Reference
No information avaliable
Dibucain
Molecular Weight
309.445 g/mol
Dibucain
Melting Point
No information avaliable
Dibucain
H2O Solubility
No information avaliable
Dibucain
State
Solid
Dibucain
LogP
4.86
Dibucain
Dosage Forms
Tablets for oral administration (25 mg, 50 mg)
Dibucain
Indication
For use in the prevention and symptomatic treatment of peripheral (labyrinthine) vertigo and associated nausea and vomiting that occur in such conditions as Meniere's disease and surgery of the middle and inner ear. Also for the control of nausea and vomiting associated with postoperative states, malignant neoplasms, labyrinthine disturbances, antineoplastic agent therapy, radiation sickness, and infectious diseases.
Dibucain
Pharmacology
No information avaliable
Dibucain
Absorption
Well absorbed from gastrointestinal tract following oral administration.
Dibucain
side effects and Toxicity
Symptoms of overdose include drowsiness (severe); shortness of breath or troubled breathing; unusual tiredness or weakness (severe).
Dibucain
Patient Information
No information avaliable
Dibucain
Organisms Affected
Humans and other mammals